search
Long COVID patients
Trends
- 1Study examines post-COVID risks in asthma and COPD patients▼Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease
A new cross-sectional study published in Nature examines the risk factors associated with post-COVID-19 symptoms in patients with asthma and chronic obstructive pulmonary disease. The research aims to identify which characteristics make people with these chronic lung conditions more likely to experience lingering symptoms after infection, a question of ongoing concern for respiratory clinicians.
- 2
Reporting from The Sick Times features interviews with five people serving time in prison who have Long COVID, describing how they are effectively invisible within prison healthcare systems. The piece highlights limited medical care, lack of recognition of their condition, and the difficulty of advocating for themselves while incarcerated, drawing attention to an overlooked group in the wider Long COVID conversation.
- 3NIH trial finds antiviral drug fails to improve Long COVID symptoms●Antiviral drug did not improve Long COVID symptoms
Researchers with the National Institutes of Health report that an antiviral drug did not improve symptoms in patients with Long COVID. The finding comes from a federally funded trial and adds to a string of disappointing results in the search for effective treatments for the lingering condition, which affects millions of people worldwide. Clinicians and patient advocates say the result underscores how little proven therapy exists for the illness.